ZBH

#612
Zimmer Biomet Holdings, Inc. Common Stock
101.3 6 USD
+0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
99.01
101.71
Intervallo Annuale
79.12
103.69
Variazione giornaliera
+1.96%
Variazione Mensile
+5.53%
Variazione di 6 mesi
+3.55%
Variazione Annuale
-2.07%
Chiusura Precedente
99.4 1
Open
99.4 0
Minimo
99.0 1
Massimo
101.7 1
Volume
92
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q1 FY2026
8-K

ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2007

Full document

Business Context and Reporting Period

This Form 8-K Current Report was filed by Zimmer Holdings, Inc. on May 7, 2007. The filing primarily addresses corporate governance changes, specifically the appointment of new senior financial officers and the associated compensatory arrangements.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and executive compensation rather than financial performance results.

Material Changes

  • Executive Appointments: Derek M. Davis was appointed Vice President, Finance and Corporate Controller, and Chief Accounting Officer effective May 7, 2007.
  • Executive Promotion: James T. Crines was promoted to Executive Vice President, Finance and Chief Financial Officer effective May 1, 2007.
  • Compensation Awards: In connection with his promotion, Mr. Davis received two awards under the 2006 Stock Incentive Plan with a grant date of May 9, 2007:
    • 5,500 non-qualified stock options vesting ratably over four years.
    • Up to 6,250 performance-based restricted stock units (target of 2,083) for a performance period ending December 31, 2008.
  • Severance Agreement: Mr. Davis is expected to enter into a change in control severance agreement in the form attached as Exhibit 10.1.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary contingency noted is the pending approval of specific performance conditions for Mr. Davis's restricted stock units by the Compensation and Management Development Committee within 90 days.

Investor Verification Checklist

  • Verify the specific performance conditions for the 6,250 restricted stock units once approved by the Committee.
  • Review the terms of the Change in Control Severance Agreement (Exhibit 10.1) to understand potential payout obligations.
  • Confirm the vesting schedule details for the 5,500 non-qualified stock options granted to Mr. Davis.

Notizie